prednisone has been researched along with Leukemia, Promyelocytic, Acute in 15 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
Leukemia, Promyelocytic, Acute: An acute myeloid leukemia in which abnormal PROMYELOCYTES predominate. It is frequently associated with DISSEMINATED INTRAVASCULAR COAGULATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We describe a patient with acute promyelocytic leukemia (APL) who was successfully induced into remission with all-trans retinoic acid (ATRA) and idarubicin, but developed myelodysplastic syndrome (MDS) with monosomy 7 shortly after conclusion of maintenance therapy with idarubicin alternating with 6-mercaptopurine, vincristine, methotrexate and prednisone." | 3.69 | Myelodysplastic syndrome following successful therapy of acute promyelocytic leukemia. ( Bseiso, AW; Estey, E; Kantarjian, H, 1997) |
| "18 patients with acute promyelocytic leukemia (APL) were treated with HATP (Harringtonine, Adriamycin, Thioguanine, Prednisone) chemotherapy combined with chinese traditional medications." | 3.68 | [HATP chemotherapy combined with Chinese traditional medications in treating acute promyelocytic leukemia]. ( Guo, AX; Huang, SL; Wang, QE, 1993) |
| "Oral prednisone was administered and the lesions started to improve within 48 hours." | 1.31 | Sweet's syndrome during the treatment of acute promyelocytic leukemia with all-trans retinoic acid. ( Bae, YD; Choi, JY; Heo, PS; Lee, JA; Lee, KS; Park, CJ; Park, YS, 2001) |
| "The association of leukemia and multiple myeloma is well described usually as a complication of chemotherapy but also in the absence of chemotherapy or at diagnosis." | 1.30 | Acute promyelocytic leukaemia complicating multiple myeloma: evidence of different cell lineages. ( Dunkley, S; Gibson, J; Iland, H; Joshua, D; Li, C, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (6.67) | 18.7374 |
| 1990's | 9 (60.00) | 18.2507 |
| 2000's | 3 (20.00) | 29.6817 |
| 2010's | 2 (13.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdullah, AS | 1 |
| Adel, AM | 1 |
| Hussein, RM | 1 |
| Abdullah, MA | 1 |
| Yousaf, A | 1 |
| Mudawi, D | 1 |
| Mohamed, SF | 1 |
| Nashwan, AJ | 1 |
| Soliman, D | 1 |
| Ibrahim, F | 1 |
| Yassin, MA | 1 |
| Creutzig, U | 1 |
| Zimmermann, M | 1 |
| Dworzak, MN | 1 |
| Ritter, J | 1 |
| Schellong, G | 1 |
| Reinhardt, D | 1 |
| Aversa, SM | 1 |
| Trentin, C | 1 |
| Sorarů, M | 1 |
| Di Bona, E | 1 |
| Marino, D | 1 |
| Canova, F | 1 |
| Salvagno, L | 1 |
| Adami, F | 1 |
| Garcia-Manero, G | 1 |
| Kantarjian, HM | 2 |
| Kornblau, S | 1 |
| Estey, E | 3 |
| WOODLIFF, HJ | 1 |
| KAKULAS, BA | 1 |
| Sun, GL | 1 |
| Ouyang, RR | 1 |
| Chen, SJ | 1 |
| Gu, YZ | 1 |
| Huang, LA | 1 |
| Lu, JX | 1 |
| Wang, ZY | 2 |
| Dreosti, LM | 1 |
| Bezwoda, W | 1 |
| Gunter, K | 1 |
| Tomas, JF | 1 |
| Escudero, A | 1 |
| Fernandez-Ranada, JM | 1 |
| Guo, AX | 1 |
| Huang, SL | 1 |
| Wang, QE | 1 |
| Ghaddar, HM | 1 |
| Pierce, S | 2 |
| Freireich, EJ | 1 |
| Keating, MJ | 1 |
| Estey, EH | 1 |
| Bseiso, AW | 1 |
| Kantarjian, H | 2 |
| Thall, PF | 1 |
| Keating, M | 1 |
| Dunkley, S | 1 |
| Gibson, J | 1 |
| Iland, H | 1 |
| Li, C | 1 |
| Joshua, D | 1 |
| Park, CJ | 1 |
| Bae, YD | 1 |
| Choi, JY | 1 |
| Heo, PS | 1 |
| Lee, KS | 1 |
| Park, YS | 1 |
| Lee, JA | 1 |
| Blazsek, I | 1 |
| Farabos, C | 1 |
| Musset, M | 1 |
| Goldschmidt, E | 1 |
| Comisso, M | 1 |
| Benavides, M | 1 |
| Labat, ML | 1 |
| Mathé, G | 1 |
| Misset, JL | 1 |
1 review available for prednisone and Leukemia, Promyelocytic, Acute
| Article | Year |
|---|---|
Development of a curative treatment within the AML-BFM studies.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Cranial Irradiatio | 2013 |
3 trials available for prednisone and Leukemia, Promyelocytic, Acute
| Article | Year |
|---|---|
Treatment of acute promyelocytic leukemia with all-trans retinoic acid. A five-year experience.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cy | 1993 |
Amsacrine and continuous-infusion high-dose cytosine arabinoside as induction therapy for patients with newly-diagnosed acute myelogenous leukemia.
Topics: Acute Disease; Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Amsacrine; Antineoplastic Co | 1996 |
Treatment of newly diagnosed acute promyelocytic leukemia without cytarabine.
Topics: Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols | 1997 |
11 other studies available for prednisone and Leukemia, Promyelocytic, Acute
| Article | Year |
|---|---|
Hypercalcemia and acute pancreatitis in a male patient with acute promyelocytic leukemia and pulmonary tuberculosis.
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Causality; Febrile Neut | 2018 |
Acute promyelocytic leukemia after Stanford V plus radiotherapy for advanced Hodgkin lymphoma.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Doxorubicin | 2009 |
Therapy-related myelodysplastic syndrome or acute myelogenous leukemia in patients with acute promyelocytic leukemia (APL).
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Leukem | 2002 |
ACUTE PROMYELOCYTIC LEUKAEMIA.
Topics: Anemia; Anemia, Myelophthisic; Blood Cell Count; Blood Sedimentation; Bone Marrow Examination; Hemor | 1964 |
Bone marrow necrosis following ALL-trans retinoic acid therapy for acute promyelocytic leukaemia.
Topics: Bone Marrow; Female; Humans; Immunologic Factors; Leukemia, Promyelocytic, Acute; Leukocyte Count; L | 1994 |
All-trans retinoic acid treatment and Sweet syndrome.
Topics: Aged; Aged, 80 and over; Female; Humans; Leukemia, Promyelocytic, Acute; Prednisone; Sweet Syndrome; | 1994 |
[HATP chemotherapy combined with Chinese traditional medications in treating acute promyelocytic leukemia].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Drugs, Chinese Herba | 1993 |
Myelodysplastic syndrome following successful therapy of acute promyelocytic leukemia.
Topics: Adult; Anemia, Refractory, with Excess of Blasts; Antineoplastic Combined Chemotherapy Protocols; Fe | 1997 |
Acute promyelocytic leukaemia complicating multiple myeloma: evidence of different cell lineages.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; | 1999 |
Sweet's syndrome during the treatment of acute promyelocytic leukemia with all-trans retinoic acid.
Topics: Adult; Biopsy, Needle; Female; Follow-Up Studies; Humans; Leukemia, Promyelocytic, Acute; Prednisone | 2001 |
Retinoic acid in mono- or combined differentiation therapy of myelodysplasia and acute promyelocytic leukemia.
Topics: Bone Marrow; Calcitriol; Cells, Cultured; Drug Therapy, Combination; Humans; Leukemia, Promyelocytic | 1991 |